Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 11, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen has proposed for election to its supervisory board Elizabeth Tallet and Vera Kallmeyer. Tallet has been president and CEO of Transcell Technologies, president of Centocor Pharmaceuticals, and director of worldwide strategic planning for Warner Lambert. Kallmeyer is a professor in the Department of Neurosurgery at the Stanford University School of Medicine, and she formerly was VP of corporate development at Aviron. Qiagen's shareholders will vote on their election at the firm's annual general meeting, which is scheduled for June 30.

Agendia has added three new faces to its executive team. The company has named David Macdonald to be COO, Mark Willig to be executive VP of North American sales, and Doug Bradley as VP of global marketing.

Macdonald has been involved in commercializing clinical diagnostics and lab services tools at Nanogen, AltheaDx, Behring Diagnostics, and the Nichols Institute. Willig was GM and chief commercial officer at Exiqon, VP of Global Sales for Thermo Fisher's pathology business, and he worked at Myriad Genetics and Abbott Diagnostics. Bradley has worked at Coherent Medical, Allergan, SenoRx, and at Vertos Medical.

Joseph Nixon has taken on the post of business development director at the North Carolina Biotechnology Center in Research Triangle Park. Nixon formerly was involved in development and licensing at Novartis and Alkermes, and he worked with the life sciences start-up NetGenics and the Cleveland Clinic Foundation.

Integrated Diagnostics has appointed Jay Moyes to be an independent director. Moyes is the former CFO of Myriad Genetics and also previously served as CFO at XDx and at Genmark.

Swift Biosciences said this week that Steve Spotts has joined the company as chief commercial officer. Prior to joining Swift, Spotts was commercial modality leader for label-free products at GE Healthcare, and before that he was vice president of sales and marketing at MicroCal. Spotts has also served as vice president of sales and marketing and vice president of marketing at Pharmacia Biotech (now GE Healthcare), and as a management consultant to the life science industry.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.